WO2005051321A3 - Treatment of inflammatory bowel disease through induction of indoleamine 2,3-dioxygenase - Google Patents
Treatment of inflammatory bowel disease through induction of indoleamine 2,3-dioxygenase Download PDFInfo
- Publication number
- WO2005051321A3 WO2005051321A3 PCT/US2004/039611 US2004039611W WO2005051321A3 WO 2005051321 A3 WO2005051321 A3 WO 2005051321A3 US 2004039611 W US2004039611 W US 2004039611W WO 2005051321 A3 WO2005051321 A3 WO 2005051321A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- indoleamine
- dioxygenase
- inflammatory bowel
- bowel disease
- induction
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/739—Lipopolysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/217—IFN-gamma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US52475303P | 2003-11-25 | 2003-11-25 | |
US60/524,753 | 2003-11-25 | ||
US53158703P | 2003-12-19 | 2003-12-19 | |
US60/531,587 | 2003-12-19 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2005051321A2 WO2005051321A2 (en) | 2005-06-09 |
WO2005051321A3 true WO2005051321A3 (en) | 2005-12-22 |
Family
ID=34636524
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2004/039611 WO2005051321A2 (en) | 2003-11-25 | 2004-11-24 | Treatment of inflammatory bowel disease through induction of indoleamine 2,3-dioxygenase |
Country Status (2)
Country | Link |
---|---|
US (1) | US20050191276A1 (en) |
WO (1) | WO2005051321A2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050260155A1 (en) * | 2004-05-18 | 2005-11-24 | Gopala Kovvali | Compositions and methods for treatment of ulcerative colitis |
WO2009073620A2 (en) * | 2007-11-30 | 2009-06-11 | Newlink Genetics | Ido inhibitors |
US20090253706A1 (en) * | 2008-04-03 | 2009-10-08 | Muller Alexander J | Methods and Compositions for the Treatment of Rheumatoid Arthritis and Other Inflammatory Diseases |
WO2010042433A1 (en) | 2008-10-06 | 2010-04-15 | Bristol-Myers Squibb Company | Combination of cd137 antibody and ctla-4 antibody for the treatment of proliferative diseases |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4921697A (en) * | 1985-05-30 | 1990-05-01 | Boehringer Ingelheim International Gmbh | IFN-gamma as an active substance for inhibiting and preventing degradation processes in bone |
US6833451B2 (en) * | 2000-03-20 | 2004-12-21 | Pharma-Zentrale Gmbh | Lipopolysaccharides (LPS) extracted from Escherichia coli |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4179337A (en) * | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
US6750334B1 (en) * | 1996-02-02 | 2004-06-15 | Repligen Corporation | CTLA4-immunoglobulin fusion proteins having modified effector functions and uses therefor |
US20040022787A1 (en) * | 2000-07-03 | 2004-02-05 | Robert Cohen | Methods for treating an autoimmune disease using a soluble CTLA4 molecule and a DMARD or NSAID |
-
2004
- 2004-11-24 WO PCT/US2004/039611 patent/WO2005051321A2/en active Application Filing
- 2004-11-24 US US10/997,147 patent/US20050191276A1/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4921697A (en) * | 1985-05-30 | 1990-05-01 | Boehringer Ingelheim International Gmbh | IFN-gamma as an active substance for inhibiting and preventing degradation processes in bone |
US6833451B2 (en) * | 2000-03-20 | 2004-12-21 | Pharma-Zentrale Gmbh | Lipopolysaccharides (LPS) extracted from Escherichia coli |
Also Published As
Publication number | Publication date |
---|---|
US20050191276A1 (en) | 2005-09-01 |
WO2005051321A2 (en) | 2005-06-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2004090539A3 (en) | Methods of determining efficacy of treatments of inflammatory diseases of the bowel | |
WO2004008147A3 (en) | Diagnosis and prevention of cancer cell invasion | |
MY155218A (en) | Small molecules useful in the treatment of inflammatory disease | |
WO2007007173A3 (en) | Human anti-madcam antibodies | |
WO2006003388A8 (en) | Compositions and methods for treating inflammatory disorders | |
TW200600087A (en) | Methods and compositions for treating amyloid-related diseases | |
HK1082256A1 (en) | New compounds, compositions and methods for treatment of inflammatory diseases and conditions | |
WO2004048938A3 (en) | Methods of detecting soft tissue sarcoma, compositions and methods of screening for soft tissue sarcoma modulators | |
WO2006092668A3 (en) | Fetal skin cell protein compositions for the treatment of skin conditions, disorders or diseases and methods of making and using the same | |
UA96115C2 (en) | Methods and compositions for treating amyloid-related diseases | |
WO2006069186A3 (en) | Small molecule bcl-xl/bcl-2 binding inhibitors | |
AU2003300368A8 (en) | Methods and compositions for the diagnosis, prognosis, and treatment of cancer | |
AU2002953327A0 (en) | Methods of diagnosing prognosing and treating activin associated diseases and conditions | |
WO2003075953A3 (en) | Immunomodulatory polymeric antigens for treating inflammatory pathogies | |
DE602004007268D1 (en) | CYCLOALKYLSULFANYL-SUBSTITUTED BENZOI BODHIOPHENE AS THERAPEUTIC AGENT | |
WO2007048097A3 (en) | Anbrosteeone derivatives and method of use thereof | |
WO2002039122A3 (en) | Methods for the identification and the treatment of cardiovascular disease | |
EP1727546A4 (en) | Methods and formulations for protecting cells, and for treating diseases and conditions by optimizing the intracellular concentration of nad | |
WO2005118860A3 (en) | Compositions and methods related to an intestinal inflammation and uses therefor | |
WO2005051321A3 (en) | Treatment of inflammatory bowel disease through induction of indoleamine 2,3-dioxygenase | |
CY1106409T1 (en) | QUINOLINE DERIVATIVES | |
WO2004110365A3 (en) | Liver related disease compositions and methods | |
WO2005042699A3 (en) | Modified polypeptides with therapeutic activity and methods of use | |
WO2005034857A3 (en) | Methods and compositions comprising diamines as new anti-tubercular therapeutics | |
WO2004047757A3 (en) | Diagnosing and treating hematopoietic cancers |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: DE |
|
122 | Ep: pct application non-entry in european phase |